US69404D1081 - PACB - A1C3EQ (XNAS)
PACIFIC BIOSCIENCES OF CALIFA INC Aktie
2,03 USD
Aktuelle Kurse von PACIFIC BIOSCIENCES OF CALIFA INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
PACB
|
USD
|
19.09.2024 23:17
|
2,03 USD
| 1,93 USD | 5,18 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
3,57 % | 12,78 % | 30,13 % | 23,40 % | -44,69 % | -79,03 % | -62,89 % |
Firmenprofil zu PACIFIC BIOSCIENCES OF CALIFA INC Aktie
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Investierte Fonds
Folgende Fonds haben in PACIFIC BIOSCIENCES OF CALIFA INC investiert:
Fonds | Vol. in Mio 206,70 | Anteil (%) 0,48 % |
Unternehmensdaten zur PACIFIC BIOSCIENCES OF CALIFA INC Aktie
Name PACIFIC BIOSCIENCES OF CALIFA INC
Firma Pacific Biosciences of California, Inc.
Symbol PACB
Website https://www.pacb.com
Heimatbörse
NASDAQ
WKN A1C3EQ
ISIN US69404D1081
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Devices
CEO Mr. Christian O. Henry M.B.A.
Marktkapitalisierung 431 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,8 T
Adresse 1305 O’Brien Drive, 94025 Menlo Park
IPO Datum 2010-10-27
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | P09.F |
NASDAQ | PACB |
Weitere Aktien
Investoren die PACIFIC BIOSCIENCES OF CALIFA INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024